Phase III study of Metadoxine Extended Release in adolescents and adult patients with Fragile X Syndrome

Trial Profile

Phase III study of Metadoxine Extended Release in adolescents and adult patients with Fragile X Syndrome

Planning
Phase of Trial: Phase III

Latest Information Update: 19 Feb 2016

At a glance

  • Drugs Metadoxine (Primary)
  • Indications Fragile X syndrome
  • Focus Therapeutic Use
  • Sponsors Alcobra
  • Most Recent Events

    • 19 Feb 2016 New trial record
    • 17 Feb 2016 According to Alcobra media release, company plans to initiate this trial following the November 2015 meeting with the U.S. Food and Drug Administration (FDA).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top